CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5510.31M
Enterprise Value 3339.29M
Trailing P/E 40.89
Forward P/E 1-8.63
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.68
Price/Book (mrq)23.71
Enterprise Value/Revenue 33.78
Enterprise Value/EBITDA 631.14

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 13.88%
Operating Margin (ttm)11.60%

Management Effectiveness

Return on Assets (ttm)4.09%
Return on Equity (ttm)42.45%

Income Statement

Revenue (ttm)89.84M
Revenue Per Share (ttm)1.82
Quarterly Revenue Growth (yoy)-0.60%
Gross Profit (ttm)33M
EBITDA 10.9M
Net Income Avi to Common (ttm)12.47M
Diluted EPS (ttm)0.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)173.12M
Total Cash Per Share (mrq)3.43
Total Debt (mrq)14.73M
Total Debt/Equity (mrq)68.59
Current Ratio (mrq)2.87
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)37.54M
Levered Free Cash Flow (ttm)31.07M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.21
52-Week Change 367.61%
S&P500 52-Week Change 3-0.94%
52 Week High 315.08
52 Week Low 35.42
50-Day Moving Average 310.41
200-Day Moving Average 311.60

Share Statistics

Avg Vol (3 month) 3238.72k
Avg Vol (10 day) 3191.8k
Shares Outstanding 550.53M
Float 23.75M
% Held by Insiders 139.30%
% Held by Institutions 156.52%
Shares Short (Nov 15, 2018) 41.44M
Short Ratio (Nov 15, 2018) 48.53
Short % of Float (Nov 15, 2018) 45.79%
Short % of Shares Outstanding (Nov 15, 2018) 42.86%
Shares Short (prior month Oct 15, 2018) 42.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A